At a glance
Reticulate pigment disorder is a group of conditions in which reticulated or net-like changes in skin pigmentation occur.
Typical findings may include mottled or net-like areas of increased or decreased pigmentation on the skin.
Disease Atlas / Disease detail
Educational material for understanding the features, causes, symptoms, diagnosis, management, and research questions of reticulate pigment disorder.
reticulate pigment disorder
Start with the essentials, then explore the patient and research views.
Public revision · 853bbbcb8061
A structured guide for understanding the disease and preparing for clinical conversations.
Reticulate pigment disorder is a group of conditions in which reticulated or net-like changes in skin pigmentation occur.
Typical findings may include mottled or net-like areas of increased or decreased pigmentation on the skin.
The precise cause differs by subtype, and some forms may be associated with genetic factors.
Pigment changes may be related to changes in melanin production or distribution, or to alterations in skin structure.
The pattern of onset and severity may vary among individuals according to the subtype, family history, skin characteristics, and environmental factors.
The age at onset, extent of lesions, and pattern of progression vary, and the skin changes may persist for a long time.
Diagnosis is based on a dermatological assessment that considers the appearance and distribution of lesions, their time of onset, family history, and medical history; dermoscopy, skin biopsy, or genetic testing may be considered when needed.
Pigment changes alone do not establish the diagnosis; distinguishing other pigmented skin disorders and interpreting test results in their clinical context are important.
Management involves identifying the type and extent of the skin changes, using sun protection and skin care, treating symptoms when needed, and monitoring changes over time.
No curative treatment has been established for every subtype, and treatment goals differ according to the form and symptoms.
Follow-up assesses the extent and speed of pigment changes and any new skin or systemic symptoms; trial registration alone should not be taken as proof of effectiveness or standard-of-care status.
During a clinical visit, it is helpful to review the age at onset and rate of change, family history, medications and skin exposures, accompanying symptoms, previous tests and treatments, and treatment goals.
This material is for educational purposes and does not replace individualized diagnostic or treatment guidance.
A trial registry status does not establish efficacy or regulatory approval.
MONDO · ONTOLOGY